Skip to main content

2 Result(s)

within Zhengyang Fei Remove this filter

and

  1. Article

    Open Access

    Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma

    Esophageal carcinoma is a type of cancer that occurs in the esophagus. For patients with locally advanced or metastatic esophageal squamous cell carcinoma who have either experienced disease progression follow...

    **yu Chen, Chang Fu, Lin Shen, Zhengyang Fei, Mengjie Luo… in BMC Health Services Research (2024)

    Download PDF (2295 KB) View Article

  2. No Access

    Article

    Immunotherapy Guided by Immunohistochemistry PD-L1 Testing for Patients with NSCLC: A Microsimulation Model-Based Effectiveness and Cost-Effectiveness Analysis

    On the basis of immunohistochemistry PD-L1 testing results, patients with advanced non-small cell lung cancer (NSCLC) are treated differently. Theoretically, patients with high PD-L1 expression (50% or 1%) sho...

    Mingjun Rui, Yingcheng Wang, Yunfei Li, Zhengyang Fei in BioDrugs (2024)